# A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

> **NCT06362759** · PHASE2 · COMPLETED · sponsor: **Tourmaline Bio, Inc.** · enrollment: 143 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Chronic Kidney Insufficiency
- Chronic Renal Diseases
- Chronic Renal Insufficiency
- Kidney Insufficiency, Chronic
- C-Reactive Protein
- High Sensitivity C-Reactive Protein
- Hs-CRP
- hsCRP

## Interventions

- **DRUG:** TOUR006 - 50 MG
- **DRUG:** TOUR006 - 25 MG
- **DRUG:** TOUR006 - 15 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06362759
- **Lead sponsor:** Tourmaline Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-15
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-12-04
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362759, "A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06362759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*